These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 8810934

  • 1. A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis.
    Luomanmäki K, Grankvist S, Hallert C, Jauro I, Ketola K, Kim HC, Kiviniemi H, Koskivirta H, Sörskog L, Vilkko P.
    J Intern Med; 1996 Aug; 240(2):85-92. PubMed ID: 8810934
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin.
    Partsch H, Kechavarz B, Mostbeck A, Köhn H, Lipp C.
    J Vasc Surg; 1996 Nov; 24(5):774-82. PubMed ID: 8918323
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin Trial Group.
    Lindmarker P, Holmström M.
    J Intern Med; 1996 Dec; 240(6):395-401. PubMed ID: 9010387
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J, Schmidt JA, Koppenhagen K, Tolle A, Huisman MV, Büller HR.
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
    Reeves JH, Cumming AR, Gallagher L, O'Brien JL, Santamaria JD.
    Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: a retrospective analysis.
    Holmström M, Aberg W, Lockner D, Paul C.
    Thromb Haemost; 1999 Oct; 82(4):1222-6. PubMed ID: 10544902
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis.
    Avritscher EB, Cantor SB, Shih YC, Escalante CP, Rivera E, Elting LS.
    Support Care Cancer; 2004 Jul; 12(7):531-6. PubMed ID: 14986076
    [Abstract] [Full Text] [Related]

  • 18. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV, Howes J, Sharma V, Kadziola Z.
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A 6-month venographic follow-up in 164 patients with acute deep vein thrombosis.
    Holmström M, Lindmarker P, Granqvist S, Johnsson H, Lockner D.
    Thromb Haemost; 1997 Aug; 78(2):803-7. PubMed ID: 9268175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.